CORONAVIRUS STATEMENT – 16 MARCH 2020
WEP Clinical (“WEP”)’s management team met on 16 March [...]
WEP CLINICAL AND WELLSTAT THERAPEUTICS CORPORATION ENTER INTO NEW PARTNERSHIP FOR THE NAMED PATIENT SUPPLY OF VISTOGARD® (URIDINE TRIACETATE)
WEP Clinical, the specialist pharmaceutical services company, announces that [...]
WEP CLINICAL LAUNCHES 24/7/365 EMERGENCY MEDICINES SUPPLY SERVICE
WEP Clinical, the specialist pharmaceutical services company, has announced [...]
WEP CLINICAL LAUNCHES NITISINONE MDK IN THE EU ON BEHALF OF MENDELIKABS INC.
WEP Clinical, the specialist pharmaceutical services company, has announced [...]
WEP CLINICAL RELEASES NEW COMPANY VIDEO
At WEP Clinical, our mission is to help patients [...]
WEP CLINICAL ANNOUNCES RARE DISEASE DAY CAMPAIGN
WEP Clinical, the specialist pharmaceutical services company, is proud [...]
WEP CLINICAL ANNOUNCES NEW UK WAREHOUSE FACILITIES
WEP Clinical (WEP), the specialist pharmaceutical services company, is [...]
WEP CLINICAL ANNOUNCES NEW US OFFICE FACILITIES
WEP Clinical (WEP) is excited to announce that it [...]
WEP Clinical and MendeliKABS Inc. enter exclusive Named Patient distribution agreement for MDK-Nitisinone
WEP Clinical, a global pharmaceutical and services company, and MendeliKABS [...]
WE PHARMA ANNOUNCES NAME CHANGE TO WEP CLINICAL
As of 25 November 2016, our company name will [...]